日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors

药物基因组学合成致死筛选揭示了 NF1 相关肿瘤治疗的隐藏弱点和新治疗方法

Kyle B Williams, Alex T Larsson, Bryant J Keller, Katherine E Chaney, Rory L Williams, Minu M Bhunia, Garrett M Draper, Tyler A Jubenville, Sue K Rathe, Christopher L Moertel, Nancy Ratner, David A Largaespada

SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis

SEMA4C 是限制骨肉瘤生长、进展和转移的新靶点

Branden A Smeester, Nicholas J Slipek, Emily J Pomeroy, Heather E Bomberger, Ghaidan A Shamsan, Joseph J Peterson, Margaret R Crosby, Garrett M Draper, Kelsie L Becklin, Eric P Rahrmann, James B McCarthy, David J Odde, David K Wood, David A Largaespada, Branden S Moriarity

Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic Osteosarcoma

ZNF217 在加速肿瘤发展中的作用以及针对 ZNF217 诱导的 PI3K-AKT 信号治疗转移性骨肉瘤的意义

Branden A Smeester #, Garrett M Draper #, Nicholas J Slipek, Alex T Larsson, Natalie Stratton, Emily J Pomeroy, Kelsie L Becklin, Kenta Yamamoto, Kyle B Williams, Kanut Laoharawee, Joseph J Peterson, Juan E Abrahante, Susan K Rathe, Lauren J Mills, Margaret R Crosby, Wendy A Hudson, Eric P Rahrmann,

Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

利用Cas9碱基编辑器实现高效的多重人类T细胞工程改造,避免双链断裂

Beau R Webber ,Cara-Lin Lonetree ,Mitchell G Kluesner ,Matthew J Johnson ,Emily J Pomeroy ,Miechaleen D Diers ,Walker S Lahr ,Garrett M Draper ,Nicholas J Slipek ,Branden A Smeester ,Klaus N Lovendahl ,Amber N McElroy ,Wendy R Gordon ,Mark J Osborn ,Branden S Moriarity